Aspirin
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.
Aspirin may have ‘direct role’ in augmenting the immune system to fight colorectal cancer
Whereas previous studies have shown aspirin use decreases incidence and mortality of colorectal cancer, researchers may now have insight into why this occurs, according to study results published in Cancer.
Low-dose aspirin ‘significantly’ reduced hepatic fat in MASLD by more than 10% vs. placebo
Daily low-dose aspirin “significantly reduced” hepatic fat quantity at 6 months compared with placebo among patients with metabolic dysfunction-associated steatotic liver disease, according to preliminary trial results published in JAMA.
Aspirin nonadherence after MI increases long-term risk for recurrent MI, stroke, death
People who did not adhere to a long-term aspirin regimen after an MI had a higher risk for recurrent MI, stroke or death, although the risk appeared less pronounced among older adults and women, according to study results.
Aspirin use in older adults inconsistent with guidelines, researchers find
Many older adults who regularly use aspirin do not have a history of CVD, demonstrating a lack of adherence to recent guidelines, according to a recent survey from the National Poll on Healthy Aging.
Low-dose aspirin in pregnancy does not affect children’s neurodevelopment
Prenatal low-dose aspirin exposure was not associated with negative neurodevelopmental outcomes in children by age 3 years, according to study results published in Obstetrics & Gynecology.
Apixaban did not prevent recurrent stroke vs. aspirin in atrial cardiopathy without AF
Anticoagulation with apixaban after cryptogenic stroke with evidence of atrial cardiopathy and no atrial fibrillation did not prevent recurrent stroke compared with aspirin, researchers reported.
Prophylactic probiotic ‘ineffective’ in mitigating GI permeability associated with aspirin
Consumption of a prophylactic probiotic supplement of Lactobacilli did not prevent or mitigate the effects of gastrointestinal permeability associated with an acute aspirin challenge in healthy individuals, data showed.
Patient factors impact risk of venous thromboembolism after THA, TKA
According to published results, underlying patient factors may have a greater impact on risk of venous thromboembolism in patients undergoing total hip or knee arthroplasty compared with thromboprophylactic agents.
Low-dose aspirin ‘potential therapeutic option’ for MASLD, markedly reduces steatosis
BOSTON — Low-dose aspirin significantly reduced steatosis in patients with metabolic dysfunction-associated steatotic liver disease and improved markers of liver inflammation and fibrosis, according to data presented at The Liver Meeting.